Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Brain and reflex testing to distinguish organic and functional tics

Official title: Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques

Run by National Institutes of Health Clinical Center (CC) · NCT07137442 · Data updated 2026-11-12

This test uses EEG, EMG, blink reflex, and pre-pulse inhibition recordings to see if brain and reflex signals can tell apart adults with organic tics, adults with functional tics, and people without tics.

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment75 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedNovember 15, 2026
Main results expectedAugust 1, 2034
Study endsAugust 1, 2034
Registry record updatedNovember 10, 2026
Trial IDNCT07137442 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with a diagnosis of motor tics (organic) or functional motor tics, and healthy adults with no neurological or psychiatric disorders, are appropriate candidates.

Probably not a fit

People under 18, those unable to give informed consent, and those currently using tic-suppressing antipsychotics or with heavy alcohol or illicit drug use are not eligible and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with motor tics, adults with functional motor tics, and healthy controls attend a single 4-hour clinic visit (which can be split over 1–2 days) for physiological testing. Participants wear EEG and EMG sensors while clinicians record brain activity around tic events, focusing on beta power at the vertex and Bereitschaftspotential signals. Additional measures include blink reflex testing and pre-pulse inhibition to probe subcortical excitability. The primary aim is to see if cortical excitability before tics differs between groups, with exploratory analysis of other frequency bands and reflex measures.

Why it matters

Potential benefit: If successful, the tests could help doctors more accurately tell whether a patient's tics are organic or functional, leading to more appropriate treatment plans.

How similar studies have gone: Prior studies using EEG readiness potentials, blink reflexes, and pre-pulse inhibition have shown differences between organic and functional movement disorders, but applying this combined cortical and subcortical testing specifically to tics is still an emerging approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

* Capacity to provide informed consent (self-consent)
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Male or female, aged 18-80
* Agreement to adhere to Lifestyle Considerations prior to and during the physiological testing visit.

Inclusion criteria for patients with functional tics or tics

\- Diagnosed with functional motor tics or motor tics

Inclusion criteria for healthy controls

\- Have no neurological or psychiatric disorders established by history and physical/neurological examination

EXCLUSION CRITERIA:

* Self-reported consumption of \>14 alcoholic drinks/week\* for a man and \>7 alcoholic drinks/week for a woman
* Use of prescription drugs and other illicit drugs that may suppress tics such as dopamine blocking agents and antipsychotics during a certain time period prior to the

neurophysiological testing session.\*\*

* Clinically significant abnormal movements on neurological examination except for tics.
* Contraindications to EEG or EMG procedures, including skin lesions at electrode sites or hypersensitivity to electrode materials.
* History of or current brain tumor, stroke, head trauma with loss of consciousness.
* Epilepsy or seizures in the past 12 months.
* Have a Baclofen pump, or have neurostimulators for pain.
* Pregnant women
* Self-reported current major depression or Beck Depression Inventory II (BDI-II) score \>19, Generalized Anxiety Disorder 7-item scale (GAD-7) score \> 9, or any major current psychiatric illness.
* Presence of any metal in the eye or skull area such as a brain stimulator, shrapnel, surgical metal, clips in the brain, cochlear implants, metal fragments in the eye.
* Presence of pacemaker, intracardiac lines, implanted pumps or stimulators.
* Unable to comply with the requirements of the study procedures.
* Vocal tics only tested with Modified Rush Video-Based Tic Rating Scale.
* Low Premonitory Urge for Tics Scale (PUTS) score \< 9 (maximum 36) with low willingness for tics (patient groups only, not applicable in healthy volunteers).

  * Note: 1 standard alcoholic drink is 0.6 ounce (14 grams) of pure alcohol.

    * Note: The certain time period depends on different drugs used. Five half-lives will be selected. The drug is considered effectively eliminated from the body after this time period because the concentration of the drug reaches around 3% of the orininal concentration.

Where it's running

  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Debra J Ehrlich, M.D. — National Institute of Neurological Disorders and Stroke (NINDS)
  • Study coordinator: Zhen Ni, Ph.D.
  • Email: zhen.ni@nih.gov
  • Phone: (301) 435-2175

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.